April 26, 2025 Asieris and Subsidiary Baylink Present Study Results on AI Small Molecules and ADC Platform at the 2025 AACR Annual Meeting
April 18, 2025 Asieris Pharmaceuticals Releases 2024 Annual Report, with Revenue Exceeding RMB 200M in 1st Year of Commercialization and Innovative Portfolio Accelerating Toward Launch
March 27, 2025 Asieris’ Subsidiary Baylink Biosciences to Present Two Research Achievements at the 2025 American Association for Cancer Research Annual Meeting
March 26, 2025 Asieris’ Research Achievements Selected for Presentation at the 2025 American Association for Cancer Research Annual Meeting